Emile Battat Biography and Net Worth

Director of Atrion


Mr. Battat has been a director of the Company since 1987 and has served as Chairman of the Board of the Company since January 1998. He served as President and Chief Executive Officer of the Company from October 1998 until May 2011. He has served as an officer or director of one or more of the Company’s subsidiaries since 1998. Mr. Battat holds Bachelor of Science and Master of Science degrees in Mechanical Engineering from Massachusetts Institute of Technology and a Master of Business Administration degree from Harvard University. He is an associate member of Sigma Xi, a scientific honor society.

What is Emile A. Battat's net worth?

The estimated net worth of Emile A. Battat is at least $68.92 million as of December 11th, 2019. Mr. Battat owns 148,673 shares of Atrion stock worth more than $68,917,369 as of March 29th. This net worth evaluation does not reflect any other assets that Mr. Battat may own. Additionally, Mr. Battat receives an annual salary of $906,120.00 as Director at Atrion. Learn More about Emile A. Battat's net worth.

How old is Emile A. Battat?

Mr. Battat is currently 86 years old. There are 1 older executives and no younger executives at Atrion. Learn More on Emile A. Battat's age.

What is Emile A. Battat's salary?

As the Director of Atrion Co., Mr. Battat earns $906,120.00 per year. The highest earning executive at Atrion is Mr. David A. Battat, President & CEO, who commands a salary of $1,540,000.00 per year. Learn More on Emile A. Battat's salary.

How do I contact Emile A. Battat?

The corporate mailing address for Mr. Battat and other Atrion executives is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. Atrion can also be reached via phone at (972) 390-9800 and via email at [email protected]. Learn More on Emile A. Battat's contact information.

Has Emile A. Battat been buying or selling shares of Atrion?

Emile A. Battat has not been actively trading shares of Atrion within the last three months. Most recently, Emile A. Battat sold 3 shares of the business's stock in a transaction on Monday, December 20th. The shares were sold at an average price of $713.00, for a transaction totalling $2,139.00. Learn More on Emile A. Battat's trading history.

Are insiders buying or selling shares of Atrion?

In the last year, Atrion insiders bought shares 2 times. They purchased a total of 600 shares worth more than $185,904.00. The most recent insider tranaction occured on December, 1st when Director Preston G Athey bought 300 shares worth more than $95,904.00. Insiders at Atrion own 22.7% of the company. Learn More about insider trades at Atrion.

Information on this page was last updated on 12/1/2023.

Emile A. Battat Insider Trading History at Atrion

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Sell3$713.00$2,139.00View SEC Filing Icon  
12/14/2021Sell261$683.45$178,380.45View SEC Filing Icon  
12/11/2019Buy1,000$686.25$686,250.00148,673View SEC Filing Icon  
9/6/2017Sell1,408$652.91$919,297.28148,881View SEC Filing Icon  
6/9/2017Sell100$585.50$58,550.00149,081View SEC Filing Icon  
6/6/2017Sell699$580.84$406,007.16149,480View SEC Filing Icon  
6/2/2017Sell1,217$564.04$686,436.68150,797View SEC Filing Icon  
5/26/2017Sell655$546.31$357,833.05151,297View SEC Filing Icon  
5/17/2017Sell721$542.64$391,243.44152,112View SEC Filing Icon  
11/14/2016Sell2,093$452.87$947,856.91142,373View SEC Filing Icon  
11/10/2016Sell1,102$443.01$488,197.02142,968View SEC Filing Icon  
6/23/2016Sell12$432.00$5,184.00143,868View SEC Filing Icon  
6/22/2016Sell72$427.50$30,780.00143,880View SEC Filing Icon  
6/21/2016Sell1,091$429.00$468,039.00144,617View SEC Filing Icon  
6/20/2016Sell426$429.00$182,754.00144,617View SEC Filing Icon  
6/16/2016Sell3,130$423.21$1,324,647.30147,673View SEC Filing Icon  
See Full Table

Emile A. Battat Buying and Selling Activity at Atrion

This chart shows Emile A Battat's buying and selling at Atrion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Atrion Company Overview

Atrion logo
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Read More

Today's Range

Now: $463.55
Low: $444.21
High: $467.41

50 Day Range

MA: $378.56
Low: $319.98
High: $463.55

2 Week Range

Now: $463.55
Low: $274.98
High: $670.00

Volume

29,432 shs

Average Volume

13,692 shs

Market Capitalization

$815.85 million

P/E Ratio

42.03

Dividend Yield

2.01%

Beta

0.58